Overexpression of NgBR inhibits high-fat diet-induced atherosclerosis in ApoE-deficiency mice

Background: Hyperlipidemia (hypercholesterolemia and/or hypertriglyceridemia) is a risk factor for atherosclerosis. Nogo-B receptor (NgBR) plays important roles in hepatic steatosis and cholesterol transport. However, the effect of NgBR overexpression on atherosclerosis remains unknown. Materials and Methods: Apolipoprotein E deficient (ApoE(-/-)) mice infected with adeno-associated virus (AAV)-NgBR expression vector were fed a high-fat diet for 12 weeks, followed by determination of atherosclerosis and the involved mechanisms. Results: We determined that high expression of NgBR by AAV injection mainly occurs in the liver and it can substantially inhibit en face and aortic root sinus lesions. NgBR overexpression also reduced levels of inflammatory factors in the aortic root and serum, and levels of cholesterol, triglyceride, and free fatty acids in the liver and serum. Mechanistically, NgBR overexpression increased the expression of scavenger receptor type BI and the genes for bile acid synthesis, and decreased the expression of cholesterol synthesis genes by reducing sterol regulatory element-binding protein 2 maturation in the liver, thereby reducing hypercholesterolemia. In addition, NgBR overexpression activated AMP-activated protein kinase alpha via the Ca2+ signaling pathway, which inhibited fat synthesis and improved hypertriglyceridemia. Conclusions: Taken together, our study demonstrates that overexpression of NgBR enhanced cholesterol metabolism and inhibited cholesterol/fatty acid synthesis to reduce hyperlipidemia, and reduced vascular inflammation, thereby inhibiting atherosclerosis in ApoE(-/-) mice. Our study indicates that NgBR might be a potential target for atherosclerosis treatment.

Automated summary

The overexpression of NgBR enhances cholesterol metabolism, inhibits cholesterol/fatty acid synthesis, reduces hyperlipidemia, and decreases vascular inflammation in atherosclerosis.